Regula+e - General Pharmaceutical Council
Regula+e - General Pharmaceutical Council
Regula+e - General Pharmaceutical Council
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Registrant update<br />
Update on<br />
dispensing<br />
errors<br />
A proposed amendment to the Health<br />
and Social Care Bill seeking a due diligence<br />
defence in the event of a dispensing error<br />
was withdrawn as the Bill made its way<br />
through the final stages of debate in the<br />
House of Lords.<br />
Liberal Democrat peer, Lord Tim Clement-<br />
Jones, had sought an amendment to the<br />
effect that anyone at risk of prosecution<br />
under section 67 of the Medicines Act<br />
would be able to mount a defence that<br />
they had exercised all due diligence to<br />
avoid committing such an offence.<br />
Speaking in the Lords on the withdrawal<br />
of this amendment, Health Minister in the<br />
Lords, Lord Howe, said;<br />
“The Medicines and Healthcare products<br />
Regulatory Agency (MHRA) intends to<br />
carry out a review of sanctions and<br />
penalties in medicines legislation. This will<br />
extend well beyond issues that have<br />
arisen in dispensing errors, but the review<br />
will look at the respective roles of<br />
medicines legislation and professional<br />
regulation in this area.<br />
“The possible role of a due diligence<br />
defence will remain on the table for<br />
consideration in the wider context of this<br />
review. It is worth stressing this point as<br />
due diligence defences have a well<br />
established usage in association with strict<br />
liability offences in many areas of<br />
legislation, including medicines legislation.<br />
“This will be a significant and wideranging<br />
review, and it is important to<br />
ensure that it covers the right ground. The<br />
MHRA would aim to scope the coverage,<br />
conduct and timetable of the review by<br />
September 2012.”<br />
Chief Executive and Registrar,<br />
Duncan Rudkin, said:<br />
“Our view remains that single dispensing<br />
errors, without other significant<br />
aggravating factors, will not amount to a<br />
fitness to practise concern.”<br />
Planning for<br />
the London<br />
Olympics<br />
As part of our planning for the<br />
London Olympics, we have reviewed<br />
the logistics of holding our fitness to<br />
practise hearings In London and at<br />
other locations. We have decided<br />
that from 26 July to 7 September,<br />
our hearings will be held at:<br />
Maple House (first floor)<br />
150 Corporation Street<br />
Birmingham B4 6TB<br />
We will ensure that registrants,<br />
witnesses, advocates, and others<br />
affected by this move are made aware<br />
of this change of location.<br />
The London Olympics will bring an<br />
influx of visitors, staff, and athletes to<br />
Great Britain. Resources to assist with<br />
planning and business continuity<br />
include the Royal <strong>Pharmaceutical</strong><br />
Society’s dedicated webpage at<br />
http://www.rpharms.com/<br />
your-day-to-day-practice/pharmacyand-the-olympics.asp<br />
4 <strong>Regula+e</strong>: March 2012 | Issue 4